Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Data in Brief|January 1, 2020
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determinationChristine Schmitz, Andreas Hüttmann, Stefan P Müller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 1, 2005
Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rowsThomas Beyer, Sandra Rosenbaum, Patrick Veit, et al.
Journal of Cancer Research and Clinical Oncology|October 28, 2021
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trialMartina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller, et al.
Cancer Medicine|September 14, 2020
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapyChristine Schmitz, Jan Rekowski, Stefan P Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2020
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax MethodJan Rekowski, Andreas Hüttmann, Christine Schmitz, et al.
Hematological Oncology|February 19, 2020
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trialChristine Schmitz, Jan Rekowski, Stefan P Müller, et al.
Annals of Hematology|January 6, 2019
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trialAndreas Hüttmann, Jan Rekowski, Stefan P Müller, et al.
Pageof 3